PMC:7556165 / 28268-28574 JSONTXT

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T178","span":{"begin":53,"end":240},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" Sampaio et al., 2007a,b; Fraga-Silva et al., 2008). In preclinical studies Ang1–7 displayed antifibrotic effects, protecting from deleterious myocardial hypertrophy and modulating left ventricle remodeling after myocardial infarction (MI). In animal models, Ang1–7 also showed an antiarrhythmic action (Fe"}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"744","span":{"begin":143,"end":165},"obj":"Disease"},{"id":"745","span":{"begin":213,"end":234},"obj":"Disease"}],"attributes":[{"id":"A744","pred":"pubann:denotes","subj":"744","obj":"MESH:D006332"},{"id":"A745","pred":"pubann:denotes","subj":"745","obj":"MESH:D009203"}],"text":" Sampaio et al., 2007a,b; Fraga-Silva et al., 2008). In preclinical studies Ang1–7 displayed antifibrotic effects, protecting from deleterious myocardial hypertrophy and modulating left ventricle remodeling after myocardial infarction (MI). In animal models, Ang1–7 also showed an antiarrhythmic action (Fe"}

{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T265","span":{"begin":181,"end":195},"obj":"Body_part"}],"attributes":[{"id":"A265","pred":"fma_id","subj":"T265","obj":"http://purl.org/sig/ont/fma/fma7101"}],"text":" Sampaio et al., 2007a,b; Fraga-Silva et al., 2008). In preclinical studies Ang1–7 displayed antifibrotic effects, protecting from deleterious myocardial hypertrophy and modulating left ventricle remodeling after myocardial infarction (MI). In animal models, Ang1–7 also showed an antiarrhythmic action (Fe"}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T62","span":{"begin":213,"end":234},"obj":"Disease"},{"id":"T63","span":{"begin":236,"end":238},"obj":"Disease"}],"attributes":[{"id":"A62","pred":"mondo_id","subj":"T62","obj":"http://purl.obolibrary.org/obo/MONDO_0005068"},{"id":"A63","pred":"mondo_id","subj":"T63","obj":"http://purl.obolibrary.org/obo/MONDO_0005068"}],"text":" Sampaio et al., 2007a,b; Fraga-Silva et al., 2008). In preclinical studies Ang1–7 displayed antifibrotic effects, protecting from deleterious myocardial hypertrophy and modulating left ventricle remodeling after myocardial infarction (MI). In animal models, Ang1–7 also showed an antiarrhythmic action (Fe"}

{"project":"LitCovid-sample-PD-MAT","denotations":[{"id":"T108","span":{"begin":186,"end":195},"obj":"http://purl.obolibrary.org/obo/MAT_0000497"}],"text":" Sampaio et al., 2007a,b; Fraga-Silva et al., 2008). In preclinical studies Ang1–7 displayed antifibrotic effects, protecting from deleterious myocardial hypertrophy and modulating left ventricle remodeling after myocardial infarction (MI). In animal models, Ang1–7 also showed an antiarrhythmic action (Fe"}

{"project":"LitCovid-sample-PD-HP","denotations":[{"id":"T18","span":{"begin":213,"end":234},"obj":"Phenotype"},{"id":"T19","span":{"begin":236,"end":238},"obj":"Phenotype"}],"attributes":[{"id":"A18","pred":"hp_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/HP_0001658"},{"id":"A19","pred":"hp_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/HP_0001658"}],"text":" Sampaio et al., 2007a,b; Fraga-Silva et al., 2008). In preclinical studies Ang1–7 displayed antifibrotic effects, protecting from deleterious myocardial hypertrophy and modulating left ventricle remodeling after myocardial infarction (MI). In animal models, Ang1–7 also showed an antiarrhythmic action (Fe"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T18","span":{"begin":213,"end":234},"obj":"Phenotype"},{"id":"T19","span":{"begin":236,"end":238},"obj":"Phenotype"}],"attributes":[{"id":"A18","pred":"hp_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/HP_0001658"},{"id":"A19","pred":"hp_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/HP_0001658"}],"text":" Sampaio et al., 2007a,b; Fraga-Silva et al., 2008). In preclinical studies Ang1–7 displayed antifibrotic effects, protecting from deleterious myocardial hypertrophy and modulating left ventricle remodeling after myocardial infarction (MI). In animal models, Ang1–7 also showed an antiarrhythmic action (Fe"}

{"project":"LitCovid-PubTator","denotations":[{"id":"744","span":{"begin":143,"end":165},"obj":"Disease"},{"id":"745","span":{"begin":213,"end":234},"obj":"Disease"}],"attributes":[{"id":"A744","pred":"tao:has_database_id","subj":"744","obj":"MESH:D006332"},{"id":"A745","pred":"tao:has_database_id","subj":"745","obj":"MESH:D009203"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" Sampaio et al., 2007a,b; Fraga-Silva et al., 2008). In preclinical studies Ang1–7 displayed antifibrotic effects, protecting from deleterious myocardial hypertrophy and modulating left ventricle remodeling after myocardial infarction (MI). In animal models, Ang1–7 also showed an antiarrhythmic action (Fe"}

{"project":"LitCovid-sentences","denotations":[{"id":"T178","span":{"begin":53,"end":240},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" Sampaio et al., 2007a,b; Fraga-Silva et al., 2008). In preclinical studies Ang1–7 displayed antifibrotic effects, protecting from deleterious myocardial hypertrophy and modulating left ventricle remodeling after myocardial infarction (MI). In animal models, Ang1–7 also showed an antiarrhythmic action (Fe"}